The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis
about
Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosisMechanisms of pathogenesis of emerging adenoviruses.Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytesHuman cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surfaceLentivectors encoding immunosuppressive proteins genetically engineer pancreatic beta-cells to correct diabetes in allogeneic mice.Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosisEpstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes.Inhibition of chemokine expression by adenovirus early region three (E3) genes.Inducible nitric oxide synthase expression inhibition by adenovirus E1A.Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cellsAdenovirus RIDalpha regulates endosome maturation by mimicking GTP-Rab7.E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE.The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.Cellular binding partners of the human papillomavirus E6 protein.Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.Immune regulation and evasion of Mammalian host cell immunity during viral infection.The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.Homologous recombination in E3 genes of human adenovirus species DAdenovirus RIDα uncovers a novel pathway requiring ORP1L for lipid droplet formation independent of NPC1.STAT1 interaction with E3-14.7K in monocytes affects the efficacy of oncolytic adenovirusAdenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liverThe adenovirus e3 promoter is sensitive to activation signals in human T cells.Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism.Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha.Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subsetVaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition poreCharacterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanismsInhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex.
P2860
Q22008750-54734BC0-9766-4D3A-B155-21728750FC4DQ30238495-3D6C1AF5-D10B-4E82-ABFD-FECAFD343A18Q33651199-05EE4D1E-0178-4E8F-A076-EF091ED7A627Q33825002-551B264E-7665-49ED-ADB8-DEF2C562879CQ33844897-9CB8C3A8-18B8-409A-A4CF-721C67E87544Q33848147-AE406CC6-7414-49A2-9A98-918349B7583AQ33980424-51E9396A-87C7-419B-9914-B04FD6756A8EQ34330584-C3F8555A-0BD3-4EEF-8042-8D1596DD309CQ34347245-8102F2A3-B9BB-462E-8F69-25C9C1BC3392Q34356569-E6AB5714-9BBB-404C-8BA4-30756B4C28B3Q34553626-6255C1C4-6934-482C-853F-53D42E3EC4CFQ34717215-77888D89-9CC1-4AC7-8F0E-00B1BCEE0658Q34768713-92A8CE86-AA0D-4E0A-B36A-3DF6B413B6B0Q35000763-75BAFAB8-3CD9-450D-B59B-407353477B84Q35146799-D97DB882-3190-4C81-A757-E3166CA981EDQ35802872-EF64F34B-FBD5-4A49-817A-6CE456434D69Q36176585-7D409CCC-2E0E-430A-ADE7-12BECA268A3EQ36264713-E9F8F9A3-D49D-4D1F-B624-00D8AED081F8Q36284758-91189EC8-AFA6-4271-B92D-D59D999C3A1EQ36473674-12629BD9-1830-429E-AE9A-A3034D6EA985Q36541174-1E88C99A-24F6-4309-BBFA-E62E8F873BE8Q36832077-3B4F05A9-A53E-4CFB-AFE3-ACB5DCEF07B2Q36898915-9AA010E3-39BA-477F-B8F6-13DF9CC797D6Q37254362-19AB4A34-D43D-466E-BE1E-4BEBA951F00AQ37270583-5562C154-BBE8-4FC1-903A-F41FC5BFB82AQ37547013-744DEB13-77DF-4283-BE65-B8E4B7C6F6A2Q37576464-59FD367A-FBF8-43AF-A877-1E070985C655Q37596949-1BC5DE52-9C8D-48F1-8446-270C9FC7810BQ38332622-6B420A7F-9D0F-405A-B439-B34233BA862FQ38359241-7DB811EE-C91F-48F3-89BB-7573E69E71D3Q38365456-7310F608-0E5B-4EFA-9A8B-BB4561909FFAQ38960064-47067F6F-92C5-4F67-A4B4-19906DA15744Q39462585-EDEB5835-5AC2-4E30-B949-44DE53841869Q39582787-2D3F41D9-863C-4BD7-962A-4125BC671D40Q39594251-2350FCF7-F517-42EA-AA47-32B1A77E1DCBQ39597114-4311D242-C759-4CD7-A80C-E8A1365051C3Q39605313-F0C892CD-3A00-47DF-9D42-33C7562E2197Q39686069-56853A1A-2AC9-4126-B4BC-4DEFCD0FBAA7Q39686155-ADF6C335-DF6B-4172-97E4-6A637A805C21Q39686844-262891A2-39CE-45E3-B646-3248077EC92C
P2860
The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@ast
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@en
type
label
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@ast
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@en
prefLabel
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@ast
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@en
P2093
P2860
P1433
P1476
The adenovirus E3-10.4K/14.5K ...... tance to Fas-induced apoptosis
@en
P2093
P2860
P304
P407
P577
1997-11-01T00:00:00Z